JW
Jessica Wreksoremboko
About Jessica Wreksoremboko
Data last updated:
Jessica Wreksoremboko is a Director at Tlc Pharmaceutical Standards India Private Limited (since 2023). The company operates in Pharma. Tlc Pharmaceutical Standards India Private Limited reported revenue of ₹1.50 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tlc Pharmaceutical Standards India Private Limited U73100TS2023FTC180139 | Director | 20 Dec 2023 | 2023 | ₹1.50 Cr (FY 2025) | Active |
Board colleagues of Jessica Wreksoremboko
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alex Kazandjian | 10432563 | Tlc Pharmaceutical Standards India Private Limited | Non- Individual Subscriber |
| Ravi Shekar Yalagala | 10432562 | Tlc Pharmaceutical Standards India Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jessica Wreksoremboko
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jessica Wreksoremboko
Jessica Wreksoremboko currently holds 1 directorship: Tlc Pharmaceutical Standards India Private Limited (Director, since 20 Dec 2023, revenue ₹1.50 Cr (FY 2025)).
Jessica Wreksoremboko was first appointed on 20 Dec 2023 as Director at Tlc Pharmaceutical Standards India Private Limited.
The current boards of Jessica Wreksoremboko's companies include Alex Kazandjian (Tlc Pharmaceutical Standards India Private Limited), Ravi Shekar Yalagala (Tlc Pharmaceutical Standards India Private Limited).